Brooks Laboratories responded to NSE's April 1, 2026 query regarding significant movement in its share price.
The company confirmed all material disclosures have been made per SEBI LODR Regulation 30 within stipulated timelines.
Management stated no Unpublished Price Sensitive Information exists and price movement is purely market-driven.